New Zealand - Hospital Discharges for Malignant Neoplasm of Prostate
Since 2014, New Zealand Hospital Discharges for Malignant Neoplasm of Prostate rose 0.8% year on year. At 1,546 Hospital Discharges in 2019, the country was number 29 among other countries in Hospital Discharges for Malignant Neoplasm of Prostate. New Zealand is overtaken by Israel, which was ranked number 28 with 1,570 Hospital Discharges and is followed by Ireland at 799 Hospital Discharges. Germany, France and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. South Korea recorded the best 5 years average growth at +9.5% per year, while Ireland witnessed the worst performance at -5.7% per year.
Loading...
Date | Units (Hospital Discharges) |
---|---|
2019 | 1,546.00 |
2018 | 1,543.00 |
2017 | 1,549.00 |
2016 | 1,517.00 |
2015 | 1,526.00 |
Download all data from 2000 to 2019
How does New Zealand rank in Hospital Discharges for Malignant Neoplasm of Prostate?
# | 33 Countries | Units (Hospital Discharges) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Japan
|
184,700 | 2017 | NA | NA | View data | |
2 |
#2
Germany
|
106,773 | 2019 | +0.7 % | +3.1 % | View data | |
28 |
#28
Israel
|
1,570 | 2019 | -2.9 % | +2.9 % | View data | |
29 |
#29
New Zealand
|
1,546 | 2019 | +0.2 % | +0.8 % | View data | |
30 |
#30
Ireland
|
799 | 2019 | -7.6 % | -5.7 % | View data |